Rethinking Clinical Trials

JANUARY 31, 2024

DIHI approaches this work through four pillars of innovation: implementation and health delivery science, health technology innovation, leadership and workforce development, and best practices development and dissemination. The Health AI Partnership started with 7 organization partners and has expanded to about 20 organizations.

Production 164

Production Development Clinical Trials Clinical Trials 164

Rethinking Clinical Trials

AUGUST 22, 2022

Core Faculty, Program for Health Disparities Research. University of Minnesota School of Public Health. University of Minnesota School of Public Health. The primary outcome was a 4-part composite: hypoxemia on a home oxygen monitor, ED visit, hospitalization or death due to COVID-19. Thomas Murray, PhD. Jared Huling, PhD.

Trials 130

Trials Clinical Trials Clinical Trials Insulin 130

Rethinking Clinical Trials

AUGUST 30, 2023

   Speaker Gabriela Schmajuk, MD, MS Professor of Medicine UCSF and the San Francisco VA Slides Keywords Patient-Reported Outcomes, Rheumatoid Arthritis, EHR Key Points Clinicians rely on patient-related outcomes (PROs) to track disease and function over time in patients with rheumatoid arthritis (RA).

Trials 143

Trials Clinical Research Coordinator Medicine Clinical Trials 143

Rethinking Clinical Trials

OCTOBER 2, 2023

There are more than 50 organizations with participating in PROTEUS, including clinicians and patient advocates, research and methods organizations, clinical trials groups, funding and government agencies, and universities and health systems. The Guide is applicable to a broad range of health systems. We are pursuing funding.

Clinical Trials 154

Clinical Trials Clinical Trials Research Trials 154

Rethinking Clinical Trials

JULY 14, 2023

Tyson School of Medicine Slides Keywords Pragmatic Clinical Trial, GGC4H, Prevention Key Points Guiding Good Choices for Health Study (GGC4H) is about the Guiding Good Choices (GGC) intervention, a group-based program for parents and caregivers of younger adolescents (ages 9-14). 2) Can virtual GGC be delivered with fidelity?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

SEPTEMBER 28, 2023

This may be the only interaction the family has with a healthcare professional, so if there are needs around behavior, health, social needs they will be addressed during these visits. Based on these findings, the research team initiated a larger PARENT trial that had 3 parent coaches at federally qualified health centers.

Trials 271

Trials Clinical Trials Clinical Trials Research 271

Rethinking Clinical Trials

OCTOBER 18, 2023

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health.

Clinical Trials 118

Clinical Trials Clinical Trials Clinical Research Research 118

Rethinking Clinical Trials

MARCH 21, 2023

Goldberg Distinguished Professor and Chief of Oncology Physician-in-Chief, North Carolina Cancer Hospital Director, Cancer Outcomes Research Program University of North Carolina Slides Keywords Patient-reported outcomes, Oncology, Clinical Trials Key Points Symptoms are common in cancer care. The culture has fundamentally changed.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

JANUARY 26, 2023

This study is looking at a particular subpopulation, where there is a lack of outcomes data. EVOLVE-MI is a pragmatic, effectiveness outcome trial of Evolocumab dosed within 10 days of a myocardial infarction (MI). Study participants are managed within health systems in-line with local standard of care.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Rethinking Clinical Trials

NOVEMBER 1, 2022

Department of Population Health Sciences. Senior Vice President, Population and Public Health. Director, Vanderbilt Institute for Medicine and Public Health. Associate Professor. Duke Clinical Research Institute. Duke University School of Medicine. Russell Rothman, MD, MPP. Vanderbilt University Medical Center.

Trials 130

Trials Clinical Research Vaccination Vaccine 130

Rethinking Clinical Trials

AUGUST 18, 2022

for Health Equity and Inclusive Excellence. There are barriers at the health care professional and researcher level. When we say pragmatic = real world do we understand that health care in the real world is unfair, unjust, racist, discriminatory? The social circumstances affect health outcomes. Consuelo H.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Insulin 130

Rethinking Clinical Trials

FEBRUARY 20, 2024

             Speaker Jeffrey Carson, MD, MACP Principal Investigator and Study Chair MINT Trial Provost-New Brunswick, Rutgers Biomedical Health Sciences Distinguished Professor of Medicine Richard C. Finally, heart failure and other safety outcomes were comparable in the two transfusion groups. Reynolds, M.D.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Rethinking Clinical Trials

APRIL 18, 2023

We have people with experience with post-viral symptoms, treating ME/CFS, general COVID knowledge, biomarker experience, clinical trials, patient-reported outcomes, and more. – As people think about the health measures and outcomes, can you describe the process for how to understand and select those types of measures?

Clinical Trials 219

Clinical Trials Clinical Trials Trials Immune Response 219

Rethinking Clinical Trials

FEBRUARY 22, 2023

Patients were followed-up online by apps for Patient Reported Outcomes and claims database. In Heartline, patients will be reimbursed for effort to complete patient reported outcomes and interacting with the app. The engagement with the original Apple health study was not good, about 30-40%.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Nurses 130

Rethinking Clinical Trials

AUGUST 10, 2023

However, gamification could have serious negative effects, and the benefits of these games in health care would relate to how well or how poorly they’re gamified, based on data, execution, and use cases. What is going to keep AI in the boundaries for health hand research right now? People need to be really focused.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130

Rethinking Clinical Trials

APRIL 13, 2023

Nudges and other behavioral interventions are prevalent in industries like business and entertainment, but there is an opportunity for nudges in medicine and health care delivery. Launched in 2016, the Penn Medicine Nudge Unit is the world’s first behavioral design team embedded within a health system.

Medicine 100

Medicine Trials Cardiology Development 100

Rethinking Clinical Trials

FEBRUARY 28, 2024

Baseline state, treatment, outcome, and safety data are critical to understanding treatment benefits and risks. Outcomes including patient reported outcomes, functional assessments including via digital technology, healthcare events or mortality may require identify verification.

Clinical Trials 143

Clinical Trials Clinical Trials Trials Clinical Research 143

Rethinking Clinical Trials

DECEMBER 12, 2023

And yet goals of care discussions and their documentation remain a shortcoming in many health systems. The primary outcome was the proportion of patients with EHR-documented goals of care discussion within 30 days of randomization. The Jumpstart intervention is a communication-priming intervention.

Trials 130

Trials Medicine Clinical Trials Clinical Trials 130

Rethinking Clinical Trials

MARCH 28, 2023

                                           Speakers Erin Holve, PhD, MPH, MPP Chief Research Infrastructure Officer, Patient-Centered Outcomes Research Institute (PCORI) Russell Rothman. For now, PCORnet®.has has worked well for supporting the types of projects we want to support.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

AUGUST 4, 2022

Department of Health Research Methods, Evidence & Impact. The primary outcome had a relative risk reduction of 51% when given 7 days or less of symptoms before treatment; when the trial looked at early treated patients (less than 3 days of symptoms before treatment) the treatment effect when up to 57% risk reduction.

Trials 130

Trials Vaccination Vaccine Clinical Trials 130

Rethinking Clinical Trials

OCTOBER 13, 2022

The HandiCAP trial asked the question do intraoperative handovers of anesthesia care have an impact on patient outcomes? Short-term outcomes, surgery length of time, and level of training of the anesthesiologist were also not different between the two groups. Learn more about the HandiCAP Trial. Discussion Themes.

Trials 130

Trials Clinical Trials Clinical Trials Nurses 130

Rethinking Clinical Trials

AUGUST 28, 2023

It includes 22 family medicine, primary care and general internal medicine clinics affiliated with Duke University, the University of Iowa or Dartmouth-Hitchcock health systems. There is also a longitudinal cohort of EHR data for all patients at participating PCP clinics to assess utilization and other broad outcomes.

Trials 130

Trials Research Medicine Doctors 130

Rethinking Clinical Trials

NOVEMBER 6, 2023

Cook, PhD Senior Biostatistics Investigator, Kaiser Permanente Washington Health Research Institute Slides Keywords Individually randomized group treatments; Intervention; Randomization; Clinical trials Key Points In individually randomized trials (IRTs), individuals are randomized to either control or intervention arms. Speaker Jonathan C.

Trials 130

Trials Clinical Trials Clinical Trials Contamination 130

Rethinking Clinical Trials

SEPTEMBER 16, 2022

Department of Medical Ethics & Health Policy. Ethics, Learning Health System. Academic medical institutions may seem like the natural setting to build Learning Health Systems (LHS), but they face unique structural barriers that require leadership, focus, and intentionality to overcome. Art and Ilene Penn Professor and Chair.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Research 100

Rethinking Clinical Trials

APRIL 27, 2023

The primary composite outcome was cardiovascular mortality or hospital admission with MI, stroke, or heart failure. A patient or their nephrologist could decide to opt-out of the randomly allocated center-wide default policy but could not opt out of the symptom data but not de-identified health records. degrees Celsius.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Rethinking Clinical Trials

MAY 19, 2023

Colwill Professor and Vice Chair Department of Family and Community Medicine University of Missouri Slides Keywords Electronic Health Record, Pragmatic Clinical Trial Key Points Patients bring patient-generated home blood pressure data into the clinical workflow. The primary outcome is blood pressure at 6 months.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Rethinking Clinical Trials

OCTOBER 19, 2022

of International Health. Johns Hopkins Bloomberg School of Public Health. These data increasingly include info that might signal physical, mental health or behavioral health risks to patient-subjects (e.g. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speakers. Joseph Ali, JD.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130

World of DTC Marketing

JUNE 23, 2021

Source: STAT News Our healthcare system can’t continue to support drugs that don’t have good clinical outcomes behind them. In my career in healthcare marketing, I have done my best to understand the “science” behind certain health conditions along with how some medications can help.

Drugs 218

Drugs FDA Approval Doctors Doctor 218

Rethinking Clinical Trials

SEPTEMBER 22, 2022

Faculty of Health and Medical Sciences. and the Danish Registry of Causes of Death (a registry of long-term clinical outcomes including hospitalizations, outpatient visits, procedures, prescriptions, mortality). Hospitalization of flu is the primary outcome. Professor in Translational Cardiology and Pragmatic Randomized Trials.

Trials 130

Trials Cardiology Vaccination Vaccine 130

Rethinking Clinical Trials

DECEMBER 6, 2022

This study asks how can we better facilitate health behaviors in patients with chronic diseases and can we leverage technology? The post Grand Rounds December 2, 2022: A Randomized Controlled Trial of Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G. Medication adherence can be a barrier to effectiveness.

Trials 130

Trials Clinical Trials Clinical Trials Compliance 130

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

The Pharma Data

NOVEMBER 29, 2021

1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). WHO encourages countries to contribute the collection and sharing of hospitalized patient data through the WHO COVID-19 Clinical Data Platform to rapidly describe clinical characteristics and patient outcomes.

Vaccination 52

Vaccination Vaccine Genome Genomics 52

pharmaphorum

APRIL 14, 2022

million price tag. million if paid through an outcomes-based contract for patients with sustained transfusion independence.” US cost-effectiveness watchdog ICER has handed bluebird bio some good news ahead of its FDA advisory committee meeting for rare blood disorder gene therapy beti-cel in June, by endorsing its proposed $2.1

Gene Therapy 64

Gene Therapy Gene Marketing Clinical Trials 64

Rethinking Clinical Trials

MARCH 1, 2023

The study does not include tissue specimen collection, image submission, or patient-reported outcome instruments. To reduce the burden on sites, the study has simplified data reporting by reducing time points data, reducing the number of forms that need to be submitted, and reducing the number of data elements within a form.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Packaging 130

pharmaphorum

JUNE 8, 2021

ICER argues that Aduhelm was effectively approved on the strength of a biomarker – removing amyloid from the brain – rather than clinical outcomes, which is “puzzling” as other drugs have been shown to remove amyloid from the brain yet failed to help patients. Patrizia Cavazzoni (@FDACDERDirector) June 7, 2021. billion in 2027.

Drugs 98

Drugs Marketing FDA Approval Trials 98

pharmaphorum

JANUARY 31, 2023

This lack of trust in such a crucial industry can lead to decreased compliance, poor treatment adherence, and negative health outcomes for patients. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Regulation 87

Regulation Marketing Sales Branding 87